Title MicroRNA-33 b knockin mice for an intron of sterol regulatory element-binding factor 1 ( Srebf 1 ) exhibit reduced HDLC in vivo

Right This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

[1]  Takeshi Kimura,et al.  MicroRNAs and Lipoprotein Metabolism. , 2014, Journal of atherosclerosis and thrombosis.

[2]  Takeshi Kimura,et al.  MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice , 2013, Nature Communications.

[3]  S. Kauppinen,et al.  Pharmacological Inhibition of a MicroRNA Family in Nonhuman Primates by a Seed-Targeting 8-Mer AntimiR , 2013, Science Translational Medicine.

[4]  R. de Cabo,et al.  MicroRNA 33 Regulates Glucose Metabolism , 2013, Molecular and Cellular Biology.

[5]  Sebastian D. Mackowiak,et al.  Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.

[6]  Takeshi Kimura,et al.  MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE−/− Mice , 2012, Journal of the American Heart Association.

[7]  Takeshi Kimura,et al.  MicroRNA 26b encoded by the intron of small CTD phosphatase (SCP) 1 has an antagonistic effect on its host gene , 2012, Journal of cellular biochemistry.

[8]  K. Moore,et al.  MicroRNA modulation of cholesterol homeostasis. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[9]  Aaron N. Chang,et al.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. , 2011, The Journal of clinical investigation.

[10]  Koh Ono,et al.  MicroRNAs and cardiovascular diseases , 2011, The FEBS journal.

[11]  Takeshi Kimura,et al.  MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo , 2010, Proceedings of the National Academy of Sciences.

[12]  I. Gérin,et al.  Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation* , 2010, The Journal of Biological Chemistry.

[13]  T. Shioda,et al.  MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis , 2010, Science.

[14]  K. Moore,et al.  MiR-33 Contributes to the Regulation of Cholesterol Homeostasis , 2010, Science.

[15]  Takeshi Kimura,et al.  Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway , 2010, Cardiovascular research.

[16]  T. Osborne,et al.  Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it's been. , 2009, Genes & development.

[17]  Takeshi Kimura,et al.  Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Shimano.  SREBPs: physiology and pathophysiology of the SREBP family , 2009, The FEBS journal.

[19]  Peter J Espenshade,et al.  Regulation of sterol synthesis in eukaryotes. , 2007, Annual review of genetics.

[20]  M. Hayden,et al.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. , 2005, The Journal of clinical investigation.

[21]  Y. Fujii‐Kuriyama,et al.  HLF/HIF‐2α is a key factor in retinopathy of prematurity in association with erythropoietin , 2003, The EMBO journal.

[22]  H. Brewer,et al.  Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations Published, JLR Papers in Press, November 4, 2002. DOI 10.1194/jlr.M200414-JLR200 , 2003, Journal of Lipid Research.

[23]  M. Okazaki,et al.  Differential reactivity of two homogeneous LDL-cholesterol methods to LDL and VLDL subfractions, as demonstrated by ultracentrifugation and HPLC. , 2002, Clinical chemistry.

[24]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[25]  S. Yamashita,et al.  Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport. , 2001, Atherosclerosis.

[26]  Nancy A. Jenkins,et al.  Recombineering: a powerful new tool for mouse functional genomics , 2001, Nature Reviews Genetics.

[27]  M. Brown,et al.  Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Admon,et al.  SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene , 1993, Cell.

[29]  Ryan E. Temel,et al.  Inhibition of miR-33 a / b in non-human primates raises plasma HDL and lowers VLDL triglycerides , 2011 .

[30]  P. Seglen.  Preparation of isolated rat liver cells. , 1976, Methods in cell biology.